AstraZeneca shareholders approve CEO Soriot’s contentious 2021 pay plan, defying wishes of 4 advisory groups
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
May 11, 2021 at 11:53AM
AstraZeneca shareholders approve CEO Soriot’s contentious 2021 pay plan, defying wishes of 4 advisory groups
Welcome to vaccine education 